Navigation Links
Bioforce Receives American Botanical Council's Tyler Award
Date:3/5/2012

and have an innate curiosity to find out how they act physiologically in a human being," said Suter. "Without [scientific] data, we could rely only on tradition, hearsay, or personal experiences; with these data we are credible and gain the trust of practitioners, pharmacists, and patients. Further, carrying out research allows us to find new indications for known plants and is one of the key drivers to stay innovative and successful. And last but not least, research carried out in phytotherapy helps the whole 'phytomedical' community, as we are living in times of evidence based medicine."

According to Bioforce USA President and CEO Pierce S. Sioussat, the acceptance of herbal medicine in the United States "can only be accomplished through continued investment in clinical research using commercially available products that are manufactured in a manner that ensures batch-after-batch and year-after-year consistency. It is also important that such research have a credible forum for public disclosure, and, in this regard, the American Botanical Council plays a critical role." Bioforce USA is a partner company that will accept the ABC award on Bioforce AG's behalf.

Bioforce AG's product integrity begins by honoring one of the most important philosophies of Swiss clinical herbalist Alfred Vogel, who founded the company in 1963: insisting that the plants used in its products are grown organically on its own farms or contract farms assessed for sustainability and approved by the company itself. According to Bioforce, the company also harvests at "ideal" times, uses high-quality seed varieties, allows the plants to sufficiently mature "until they reach optimum potential," and mixes harvest batches in order to ensure consistent efficacy. Suter said that the company always uses the whole plant in its products—another of Vogel's most important founding philosophies—and processes the plants within 24 hours after harvest to guarantee a "full
'/>"/>

SOURCE American Botanical Council
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Medicsight Receives Brazilian State Food and Drug Administration Approval for ColonCAD Software
2. Angiotech receives CE Mark approval of HemoStream(TM) Chronic Dialysis Catheter
3. SGX - Lilly Merger Offer Receives Positive Opinions From Proxy Advisory Firms
4. CV Therapeutics Receives European Approval for the Brand Name Ranexa(R)
5. XTL Biopharmaceuticals Receives Notice of Non-Compliance with Nasdaq Marketplace Rule Due to Changes in Board Composition
6. BMP Sunstone Receives Production License from the SFDA to Manufacture and Market Pediatric Multivitamin Granules in the PRC
7. Biotest Diagnostics Receives FDA Clearance for Full Line of Traditional Blood Bank Reagents
8. Caliper Life Sciences Receives $1.1 Million Task Order from the EPAs ToxCast(TM) Screening Program
9. Omaxe Infrastructure & Construction Private Ltd Receives LoI for Construction of Allopathic Medical College and Associated Hospital at Saharanpur, UP With Construction Value of Approx 250 Crores
10. TorreyPines Therapeutics Receives NASDAQ Deficiency Notice
11. Gleevec Receives FDA Priority Review as First Therapy to Reduce Recurrence of Gastrointestinal Stromal Tumors After Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/20/2013)... (PRWEB) June 20, 2013 Conscires offer ... levels of interests and budgets., , ... on Scrum basics and the ScrumMaster role. In addition ... group activities and discussions on the necessary soft skills ... Scrum Team, and company-oriented Scrum implementation aspects. , ...
(Date:6/19/2013)... , June 19, 2013  U.S. Secretary of State ... at which distinguished Syngenta  scientist Mary-Dell Chilton ... 2013 World Food Prize. The prize is the foremost ... by improving the quality, quantity or availability of food ... other laureates were recognized for "revolutionary biotechnology discoveries that ...
(Date:6/19/2013)... -- Continuing its long history of proven clinical performance in ... Inc. announces the U.S. Food and Drug Administration (FDA) ... assay for use on its Access 2 immunoassay system. ... Coulter,s troponin I test for over 12 years ... to continue providing dependability to laboratories supporting emergency care," ...
(Date:6/19/2013)... , June 19, 2013 /PRNewswire/ ... Bureau presents Innovative Drug Delivery ... Technology Licensing Opportunities for Generic ... There are more ... release drugs approved all over ...
Breaking Biology Technology:Presenting Agile and Scrum Private Trainings in Kansas by Conscires Agile Practices 2Syngenta's Mary-Dell Chilton named 2013 World Food Prize laureate 2Beckman Coulter Announces FDA Clearance of New Access AccuTnI+3 Troponin I Assay for the Access 2 Immunoassay System 2Beckman Coulter Announces FDA Clearance of New Access AccuTnI+3 Troponin I Assay for the Access 2 Immunoassay System 3Innovative Drug Delivery Systems: Novel Product and Formulation Technology Licensing Opportunities for Generic Pharmaceutical Companies 2Innovative Drug Delivery Systems: Novel Product and Formulation Technology Licensing Opportunities for Generic Pharmaceutical Companies 3
... ST. LOUIS, Oct. 5 ISTO Technologies, Inc. (ISTO), ... regeneration, announced today the completion of patient enrollment in ... an injectable formulation of juvenile chondrocytes designed for the ... patients enrolled at two clinical sites. All patients enrolled ...
... Lake, N.Y. Given the many pressing concerns of the ... to lose sleep. But for those whose responsibility it is ... charged with that mission include scientists like medical researcher Steve ... develop a vaccine that will protect the public against weaponized ...
... (Nasdaq: AMGN ) today announced that results ... trials evaluating Vectibix® (panitumumab) in combination with chemotherapy (FOLFOX ... metastatic colorectal cancer (mCRC), respectively, were published online in ... "Both studies demonstrated that Vectibix administered with chemotherapy ...
Cached Biology Technology:ISTO Technologies, Inc., Completes Enrollment in Phase I NuQu Clinical Trial 2ISTO Technologies, Inc., Completes Enrollment in Phase I NuQu Clinical Trial 3Plague researchers race to beat bioterrorists 2Plague researchers race to beat bioterrorists 3Two Pivotal Vectibix® Phase 3 Studies in First and Second-Line Treatment of Metastatic Colorectal Cancer Published in the Journal of Clinical Oncology 2Two Pivotal Vectibix® Phase 3 Studies in First and Second-Line Treatment of Metastatic Colorectal Cancer Published in the Journal of Clinical Oncology 3Two Pivotal Vectibix® Phase 3 Studies in First and Second-Line Treatment of Metastatic Colorectal Cancer Published in the Journal of Clinical Oncology 4Two Pivotal Vectibix® Phase 3 Studies in First and Second-Line Treatment of Metastatic Colorectal Cancer Published in the Journal of Clinical Oncology 5Two Pivotal Vectibix® Phase 3 Studies in First and Second-Line Treatment of Metastatic Colorectal Cancer Published in the Journal of Clinical Oncology 6Two Pivotal Vectibix® Phase 3 Studies in First and Second-Line Treatment of Metastatic Colorectal Cancer Published in the Journal of Clinical Oncology 7Two Pivotal Vectibix® Phase 3 Studies in First and Second-Line Treatment of Metastatic Colorectal Cancer Published in the Journal of Clinical Oncology 8Two Pivotal Vectibix® Phase 3 Studies in First and Second-Line Treatment of Metastatic Colorectal Cancer Published in the Journal of Clinical Oncology 9Two Pivotal Vectibix® Phase 3 Studies in First and Second-Line Treatment of Metastatic Colorectal Cancer Published in the Journal of Clinical Oncology 10Two Pivotal Vectibix® Phase 3 Studies in First and Second-Line Treatment of Metastatic Colorectal Cancer Published in the Journal of Clinical Oncology 11
(Date:6/19/2013)... In the cover story for the journal ... at the University of Massachusetts Amherst describe a new ... study the function of individual proteins in individual cell ... should allow deeper insights into protein function, Chase says, ... what that single protein does when we isolate its ...
(Date:6/19/2013)... International Science Consortium (PISC) is extremely disappointed that ... has upheld a decision that requires Dow Benelux ... rats. The study will use approximately 1160 animals ... to the substance dipropylene glycol methyl ether acetate ... Community,s Regulation on the Registration, Evaluation, Authorisation and ...
(Date:6/19/2013)... Diversity Course at the Marine Biological Laboratory (MBL), ... in Microbiology site by the American Society for ... program recognizes institutions and the scientists who worked ... the science of microbiology. A ceremony unveiling ... scheduled for Saturday, June 22, 2013, at 4:30 ...
Breaking Biology News(10 mins):UMass Amherst researchers develop powerful new technique to study protein function 2UMass Amherst researchers develop powerful new technique to study protein function 3Microbial diversity course designated as a 'Milestones in Microbiology' site 2
... Nov. 17, 2011   Life Technologies Corporation ... that the company has introduced its GeneArt® Algae ... and expression systems for photosynthetic microalgae Chlamydomonas ... strains are model organisms for the study of ...
... -- Researchers have demonstrated that the employees at ... fruits and vegetables and get 50 percent more exercise ... participating in the WellSteps Turnkey Wellness Solution ... and sleep quality. Employees also demonstrated fewer hospital and ...
... might be considered a "performance enhancing" substance for athletes, ... Journal ( http://www.fasebj.org ) shows that these enhancements ... in the brain. According to the study, short- ... constricting arteries, which reduces the flow of blood to ...
Cached Biology News:GeneArt® Algae Engineering Kits by Life Technologies™ 2GeneArt® Algae Engineering Kits by Life Technologies™ 3New Study Shows Impact of Employee Wellness Efforts 2Biker's warning! EPO hits blood vessels to raise blood pressure in the brain 2
... Goat Immunogen: Goats were ... Antibody was isolated by affinity chromatography ... Goat anti- human T7 affinity purified antibodies ... bromide method. Specificity: ...
Recognizes the VZV nucleocapsid by indirect immunofluorescence and immunoprecipitation. Shows cross-reactivity to HSV....
Duck polyclonal to Cobra venom - Fab Fragment ( Abpromise for all tested applications). Antigen: Snake Venom of N. naja arta...
LIGHT DIAGNOSTICS Echovirus Blend Reagent, ~50 tests, included in kit #3340 & #3365...
Biology Products: